Skip to main content
Premium Trial:

Request an Annual Quote

Windber and Inforsense Extend Informatics Collaboration

NEW YORK, March 7 (GenomeWeb News) - The Windber Research Institute will extend its collaboration with Inforsense by licensing a customized integrative analytics platform to be used institute-wide.


Inforsense said that the collaboration has been renewed for three years. Financial details were not disclosed.


For Windber and Inforsense this deal expands a recent agreement. Last month, Windber and Erasmus University Medical Center said they planned to develop a translational medicine data-warehousing product for clinical, imaging, and proteomic and genomic data that will run on Oracle and InforSense technologies.


Windber is using several pieces of InforSense technology including its flagship informatics platform InforSense KDE; In-Oracle Environment for accessing Oracle data through the workflow interface; literature analysis add-on TextSense; and bioinformatics add-on InforSense BioSense.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.